AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *
Make it like cafepharma, but for different industries. Learn more about CompanyUnderground
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *
Make it like cafepharma, but for different industries. Learn more about CompanyUnderground
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud